GlobeNewswire
-
Lexicon Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference
07/01/2026 -
FibroBiologics CEO Issues Letter to Shareholders
07/01/2026 -
Palisade Bio Announces Strategic Equity Investment from the Crohn’s & Colitis Foundation’s IBD Ventures Program to Advance PALI-2108
07/01/2026 -
SeaStar Medical Announces 2026 Milestones
07/01/2026 -
ImmuCell to Conduct Conference Call with Investors to Discuss Strategic Change in Focus
07/01/2026 -
Vaxxas Appoints Former Merck Global Vaccines President David Peacock as CEO
07/01/2026 -
Verrica Pharmaceuticals Announces First Patient Dosed in Phase 3 Program Evaluating YCANTH® (VP-102) for the Treatment of Common Warts
07/01/2026 -
SAB BIO Strengthens Board of Directors with Appointment of New Chair and New Director
07/01/2026 -
4DMT Provides Company Update and Anticipated Development Milestones for 2026
07/01/2026 -
Egle Therapeutics Appoints John Celebi as Chief Executive Officer
07/01/2026 -
Protara Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
07/01/2026 -
Ipsen - December 2025 - Monthly information relative to the total number of voting rights and shares composing the share capital
07/01/2026 -
Ipsen - Décembre 2025 - Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social
07/01/2026 -
300 Exceptional Teen Scientists Recognized for Innovative STEM Research in Nation’s Oldest and Most Prestigious High School Competition
07/01/2026 -
AB Science reports fourth consecutive case of response from Phase 1 data for the combination of AB8939 with venetoclax for the treatment of refractory or relapsed acute myeloid leukemia
07/01/2026 -
AB Science annonce un quatrième cas consécutif de réponse avec la combinaison d’AB8939 et du venetoclax dans le traitement de la leucémie myéloïde aiguë réfractaire ou en rechute, sur la base des données de phase 1
07/01/2026 -
Comprehensive Healthcare Welcomes Community Behavioral Health Veteran as Chief Medical Officer
07/01/2026 -
GENFIT Announces 2026 Financial Calendar
07/01/2026 -
GENFIT annonce son calendrier financier pour 2026
07/01/2026
Pages